Pyxis Oncology (PYXS) announced the pricing of its registered public offering for an expected gross proceeds of approximately $110M.
Following the announcement, the PYXS stock fell ~8.8% at ~$2.64 in the after-hours trading session.
The offering includes 36.05M shares of